Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cofactor-dependent metabolic enzymes are a broad class of proteins that require non-protein chemical components, known as cofactors, to perform their biological functions (Source [1], [2]). These cofactors include metal ions and complex organic molecules, many of which are derived from essential vitamins such as thiamine (B1), riboflavin (B2), and pyridoxine (B6) (Source [3], [4]). Cofactors can be broadly categorized into essential metal ions and organic coenzymes, which may be tightly bound prosthetic groups or loosely associated cosubstrates (Source [2]). These enzymes are integral to central metabolic pathways, including the citric acid cycle, glycolysis, and the metabolism of amino acids and fatty acids. Dysregulation or mutation of these enzymes is linked to various diseases; for example, mutations in isocitrate dehydrogenase (IDH1/2) lead to the production of the oncometabolite 2-hydroxyglutarate in certain cancers (Source [1]). Therapeutic targeting of these enzymes often involves small molecules that compete with the cofactor or substrate, or drugs like isoniazid and phenelzine that interact with specific cofactor-dependent mechanisms (Source [1]). Because these enzymes are essential for normal cellular homeostasis, pharmacological intervention requires careful management to avoid systemic toxicity or secondary metabolic deficiencies (Source [3]).
Drugs targeting these enzymes typically act through competitive inhibition of the cofactor or substrate binding sites, or via covalent modification of the cofactor itself (e.g., hydrazine-based inhibitors) (Source [1]).
9 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cofactor-dependent metabolic enzyme.